Sort
82,697 grants matching “vaccine development”
Delivery of biologically active nucleic acids to epidermal cells
$1,256,097Roger L Kaspar · Transderm, Inc. · RC2 · FY2010 · AR
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA
$1,256,014University Of California San Francisco · R01 · FY2004 · CA
Advanced Development of Vaccines for Influenza
$1,256,003Uwe Staerz · Greffex, Inc. · N01 · FY2024 · AI
Microfabrication for Biomedical Research
$1,255,904Nicole Y Morgan · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2021 · EB
HIV/AIDS Vaccine Development
$1,255,483John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2017 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2016 · AI
Functional cure and virus eradication by early HAART plus vaccination with live attenuated rubella virus vectors in macaque infants and neonates
$1,255,405Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2015 · AI
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination
$1,255,141Mark M Davis · Stanford University · U19 · FY2018 · AI
Immunotherapeutics for Treatment of Flavivirus Infection
$1,254,949Erol Fikrig · Yale University · U01 · FY2008 · AI
Tulane National Primate Research Center
$1,254,800Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2009 · RR
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$1,254,565St. Jude Children'S Research Hospital · U01 · FY2001 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$1,254,541Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,254,364Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2021 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2020 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2019 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2018 · AI
Adjuvant Development Program
$1,254,141Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2012 · AI
UCSF HIV Clinical Trials Unit
$1,254,022Diane V Havlir · University Of California, San Francisco · U01 · FY2007 · AI
DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE
$1,253,959St. Jude Children'S Research Hospital · P01 · FY2002 · AI
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program
$1,253,916Karran Phillips · National Institute On Drug Abuse · ZID · FY2021 · DA
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program
$1,253,916Karran Phillips · National Institute On Drug Abuse · ZID · FY2018 · DA
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$1,253,871Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · AI
Pre-clinical study to fulfill FDA requirements for the completion of AV-1959 IND
$1,253,815Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2017 · AG